Cullinan Therapeutics Inc (CGEM)
29.42
+1.00
(+3.52%)
USD |
NASDAQ |
May 07, 11:55
Cullinan Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2021 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Mar 2021
--
Maximum
Mar 2021
--
Average
--
Median
Mar 2021
Debt to Equity Ratio Benchmarks
Fate Therapeutics Inc | 0.00 |
Viking Therapeutics Inc | -- |
Allogene Therapeutics Inc | 0.00 |
Applied Therapeutics Inc | -0.0181 |
Nkarta Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 484.18M |
Total Liabilities (Quarterly) | 30.29M |
Shareholders Equity (Quarterly) | 453.70M |